Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.

Article Details

Citation
Copy to clipboard

Fioravanti R, Bolasco A, Manna F, Rossi F, Orallo F, Yanez M, Vitali A, Ortuso F, Alcaro S

Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6479-82. doi: 10.1016/j.bmcl.2010.09.061. Epub 2010 Sep 17.

PubMed ID
20934874 [ View in PubMed
]
Abstract

A series of N-substituted-3-[(2'-hydroxy-4'-prenyloxy)-phenyl]-5-phenyl-4,5-dihydro-(1H)-pyra zolines were synthesized and tested on human monoamine oxidase-A and -B isoforms. Structure-activity relationships and molecular modelling showed that some substitutions, such as benzyloxy or chlorine atom, improve the best interaction with active site of hMAO-B.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
ClorgilineAmine oxidase [flavin-containing] AIC 50 (nM)4.47N/AN/ADetails
IproniazidAmine oxidase [flavin-containing] BIC 50 (nM)7585.78N/AN/ADetails
IsatinAmine oxidase [flavin-containing] BIC 50 (nM)7943.28N/AN/ADetails
MoclobemideAmine oxidase [flavin-containing] AIC 50 (nM)363078.05N/AN/ADetails
SelegilineAmine oxidase [flavin-containing] AIC 50 (nM)67608.3N/AN/ADetails
SelegilineAmine oxidase [flavin-containing] BIC 50 (nM)19.95N/AN/ADetails